ProQR Therapeutics
PRQR
PRQR
58 hedge funds and large institutions have $28.2M invested in ProQR Therapeutics in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
48% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 33
92% less capital invested
Capital invested by funds: $365M → $28.2M (-$337M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
58
Holding in Top 10
–
Calls
$1.67M
Puts
$67K
Top Buyers
| 1 | +$907K | |
| 2 | +$896K | |
| 3 | +$674K | |
| 4 |
Renaissance Technologies
New York
|
+$547K |
| 5 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
+$433K |
Top Sellers
| 1 | -$16M | |
| 2 | -$14.5M | |
| 3 | -$8.98M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.69M |
| 5 |
Goldman Sachs
New York
|
-$2.84M |